Controlled, non-inferiority trial of bupivacaine liposome injectable suspension

Research output: Contribution to journalArticlepeer-review

Abstract

Objectives: Recently, a bupivacaine liposome injectable suspension (BLIS) became commercially available in the veterinary market that may provide local analgesia for 72 h. The purpose of this study was to compare a BLIS incisional block with a control protocol in cats after ovariohysterectomy (OHE). The hypothesis was that a BLIS block would provide equivalent pain relief. Methods: This study was designed as a randomized, double-blind, non-inferiority trial. Students performed an OHE followed by a two-layer incisional and body wall block with either standard bupivacaine (control) or BLIS. Postoperatively, cats in the control group received robenacoxib, whereas the BLIS cats received saline. All cats were evaluated using the feline Glasgow Composite Measure Pain Scale (GCMPS) at multiple time points postoperatively. Results: There were 24 control cats and 23 BLIS cats. One cat from each group required rescue medication. The mean GCMPS scores were low and the groups were equivalent at all time points (P <0.05). This study showed that BLIS was equivalent to the control group up to 42 h and pain scores remained low up to 68 h after surgery. Conclusions and relevance: BLIS incisional block is equivalent to a control pain protocol and reduces the need for continued postoperative drug administration.

Original languageEnglish (US)
Pages (from-to)916-921
Number of pages6
JournalJournal of Feline Medicine and Surgery
Volume22
Issue number10
DOIs
StatePublished - Oct 1 2020

Keywords

  • BLIS
  • Liposomal encapsulated bupivacaine
  • analgesia
  • incisional block
  • local block
  • ovariohysterectomy

PubMed: MeSH publication types

  • Journal Article

Fingerprint Dive into the research topics of 'Controlled, non-inferiority trial of bupivacaine liposome injectable suspension'. Together they form a unique fingerprint.

Cite this